Ke Xiao Yan
Ke Xiao Yan — Chief Physician — Hematology — Peking University Third Hospital
Specialties
Mainly engaged in clinical medical treatment, teaching, and research of various blood diseases, with high expertise in the treatment of hematologic malignancies. Particularly experienced in high-dose chemotherapy for lymphoma, autologous hematopoietic stem cell transplantation, and allogeneic hematopoietic stem cell transplantation, with a special proficiency in comprehensive treatment of relapsed and refractory lymphoma. In recent years, also has unique insights into CAR-T cell immunotherapy and targeted therapy for lymphoma.
Education
Graduated from the Medical Department of Beijing Medical College in 1982 with a Bachelor of Medicine degree, and later attended the Graduate School of Beijing Medical University, where he obtained a Master's degree in Radiation Hematology and a Doctor of Medicine degree in Hematology.
Professional Experience
Department of Hematology, Peking University Third Hospital, Associate Professor and Doctoral Supervisor. In 1993, received a WHO scholarship to study at the Hematology Research Center of Boston University Hospital in the United States. From 1994 to 1996, conducted postdoctoral research in hematologic malignancies at the Dana-Farber Cancer Institute, Harvard Medical School, USA. From 1996 to 1999, served as Deputy Director of the Department of Hematology and Deputy Director of Internal Medicine at Peking University Third Hospital. From 1999 to July 2018, served as Director of the Department of Hematology at Peking University Third Hospital, primarily engaged in clinical treatment, teaching, and research of various hematologic diseases, with high expertise in the treatment of hematologic malignancies. Particularly experienced in high-dose chemotherapy, autologous hematopoietic stem cell transplantation, and allogeneic hematopoietic stem cell transplantation for lymphoma, and especially skilled in comprehensive treatment of relapsed and refractory lymphoma. In recent years, has also made unique contributions to CAR-T cell immunotherapy and targeted therapy for lymphoma. Participated in more than 70 international and domestic clinical trials related to lymphoma and has initiated the annual Northern Lymphoma Summit Forum. Renowned in China for clinical and basic research on lymphoma, and is a principal initiator of the Northern Lymphoma Collaborative Group.
Professional Roles
Executive Director of the Chinese Association of Female Physicians, Chair of the Hematology Society of the Chinese Association of Female Physicians, Executive Deputy Director of the Clinical Oncology Expert Committee of the Chinese Association of Female Physicians, Deputy Director of the Lymphoma Branch of the Geriatric Oncology Committee of the Chinese Society of Gerontology, Deputy Director of the Hematology Committee of the Chinese Medical Education Association, Standing Member of the Lymphoma Professional Committee of the Chinese Anti-Cancer Association; Member of the Leukemia and Lymphoma Group of the Hematology Branch of the Chinese Medical Association, Member of the Hematologic Oncology Professional Committee of the Chinese Anti-Cancer Association, Member of the Oncology Branch of the Chinese Medical Association, Chair of the Pharmaceutical Professional Committee of the Beijing Medical Reward Foundation, Member of the Academic Committee of the Hematology Drug Clinical Research Collaboration Group of the China Alliance for Drug Clinical Trials; Deputy Editor-in-Chief of Leukemia & Lymphoma Journal, Editorial Board Member of Chinese Journal of Experimental Hematology, Editorial Board Member of Chinese Journal of Hematology, Review Expert of the National Natural Science Foundation of China, Review Expert of the Startup Fund for Returned Overseas Scholars of the Ministry of Education; Former Director of the Hematology Specialist Branch of the Beijing Medical Association, Member of the Hematology Professional Committee of the Beijing Branch of the Chinese Medical Association, Member of the Hematology Physician Branch Committee of the Chinese Medical Doctor Association, Member of the Experimental Hematology Professional Committee of the Chinese Society of Pathophysiology.